Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius M Hoeper

Showing results (271-280 of 311) with videos related to

Pageof 32
Sort By:
Circulation|April 12, 2024
Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management EraFelix Gerhardt, Eva Fiessler, Karen M Olsson, et al.
International Journal of Cardiology|September 10, 2018
Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations from the Cologne Consensus Conference 2018Heinrike Wilkens, Stavros Konstantinides, Irene M Lang, et al.
The European Respiratory Journal|April 4, 2015
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registryJürgen Behr, Michael Kreuter, Marius M Hoeper, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 27, 2015
Long-term safety and efficacy of imatinib in pulmonary arterial hypertensionAdaani E Frost, Robyn J Barst, Marius M Hoeper, et al.
Circulation|October 5, 2011
Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registryJoanna Pepke-Zaba, Marion Delcroix, Irene Lang, et al.
The European Respiratory Journal|January 30, 2025
Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studiesMarius M Hoeper, Mardi Gomberg-Maitland, David B Badesch, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 25, 2020
Immunoglobulin deficiency as an indicator of disease severity in patients with COVID-19Faeq Husain-Syed, István Vadász, Jochen Wilhelm, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Spatial Transcriptomics Uncovers Hybrid, Pro-Inflammatory and Pro-Fibrotic Cellular Niches in Pulmonary Granuloma of Patients with Chronic SarcoidosisLeonard Christian, Hande Yilmaz, Jannik Ruwisch, et al.
Respiratory Research|March 29, 2022
Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertensionChristina A Eichstaedt, Zoe Saßmannshausen, Memoona Shaukat, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|February 8, 2023
Highlights from the International Chronic Thromboembolic Pulmonary Hypertension Congress 2021Gérald Simonneau, Elie Fadel, Anton Vonk Noordegraaf, et al.
Pageof 32

Showing results (271-280 of 311) with videos related to

Sort By:
Pageof 32
Circulation|April 12, 2024
Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management EraFelix Gerhardt, Eva Fiessler, Karen M Olsson, et al.
International Journal of Cardiology|September 10, 2018
Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations from the Cologne Consensus Conference 2018Heinrike Wilkens, Stavros Konstantinides, Irene M Lang, et al.
The European Respiratory Journal|April 4, 2015
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registryJürgen Behr, Michael Kreuter, Marius M Hoeper, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 27, 2015
Long-term safety and efficacy of imatinib in pulmonary arterial hypertensionAdaani E Frost, Robyn J Barst, Marius M Hoeper, et al.
Circulation|October 5, 2011
Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registryJoanna Pepke-Zaba, Marion Delcroix, Irene Lang, et al.
The European Respiratory Journal|January 30, 2025
Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studiesMarius M Hoeper, Mardi Gomberg-Maitland, David B Badesch, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 25, 2020
Immunoglobulin deficiency as an indicator of disease severity in patients with COVID-19Faeq Husain-Syed, István Vadász, Jochen Wilhelm, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Spatial Transcriptomics Uncovers Hybrid, Pro-Inflammatory and Pro-Fibrotic Cellular Niches in Pulmonary Granuloma of Patients with Chronic SarcoidosisLeonard Christian, Hande Yilmaz, Jannik Ruwisch, et al.
Respiratory Research|March 29, 2022
Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertensionChristina A Eichstaedt, Zoe Saßmannshausen, Memoona Shaukat, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|February 8, 2023
Highlights from the International Chronic Thromboembolic Pulmonary Hypertension Congress 2021Gérald Simonneau, Elie Fadel, Anton Vonk Noordegraaf, et al.
Pageof 32